Related Experiment Video

Updated: May 15, 2026

Preparation Of Neovascular Tissues from Human Glioma Tissues for Quantitative Proteomics Analysis of Tumor Angiogenesis
09:33

Preparation Of Neovascular Tissues from Human Glioma Tissues for Quantitative Proteomics Analysis of Tumor Angiogenesis

Published on: March 20, 2026

A therapy inactivating the tumor angiogenic factors

Cristian Morales-Rodrigo1

  • 1Departamento de Ecuaciones Diferenciales y Analisis Numerico, Facultad de Matematicas, Universidad de Sevilla, Calle Tar a s/n, 41012-Seville, Spain. cristianm@us.es

Mathematical Biosciences and Engineering : MBE
|January 15, 2013
PubMed

Insights

This study models anti-angiogenic therapy using nonlinear partial differential equations. High doses of the therapeutic agent demonstrate global existence and long-term effectiveness in tumor treatment.

Area of Science:

  • Mathematical Biology
  • Biomedical Engineering
  • Computational Oncology

Background:

  • Angiogenesis is crucial for tumor growth and metastasis.
  • Anti-angiogenic therapies aim to inhibit tumor blood vessel formation.
  • Mathematical modeling provides insights into therapy efficacy.

Purpose of the Study:

  • To develop and analyze a nonlinear partial differential equation system for anti-angiogenic therapy.
  • To investigate the impact of a novel therapeutic agent targeting tumor angiogenic factors.
  • To examine the system's behavior under high therapeutic agent doses.

Main Methods:

  • Development of a nonlinear system of partial differential equations.
  • Mathematical analysis to prove global existence of solutions.
  • Long-term time behavior analysis of the system dynamics.

Main Results:

  • Global existence of solutions for the nonlinear system is proven.
  • The study demonstrates the long-term effects of the therapeutic agent.
  • High doses of the agent show significant impact on tumor angiogenic factor dynamics.

Conclusions:

  • The developed mathematical model accurately represents anti-angiogenic therapy effects.
  • The findings support the potential of this therapeutic agent for cancer treatment.
  • Further research can explore parameter optimization for enhanced efficacy.

More Related Videos

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo08:19

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo

Published on: July 20, 2019

Monitoring Functionality and Morphology of Vasculature Recruited by Factors Secreted by Fast-growing Tumor-generating Cells09:03

Monitoring Functionality and Morphology of Vasculature Recruited by Factors Secreted by Fast-growing Tumor-generating Cells

Published on: November 23, 2014

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...